ATRX
ATRX (ATRX)
Healthcare • NYSE • $0.000.00%
Key Fundamentals
- Symbol
- ATRX
- Exchange
- NYSE
- Sector
- Healthcare
- Industry
- Biotechnology
- Price
- $0.00
- Daily Change
- 0.00%
- Market Cap
- $722
- Trailing P/E
- N/A
- Forward P/E
- N/A
- 52W High
- $0.01
- 52W Low
- $0.00
- Analyst Target
- N/A
- Dividend Yield
- N/A
- Beta
- 782.83
About ATRX
Adhera Therapeutics, Inc., a biotech company, focuses on the discovery, development, and commercialization of small molecule drugs. The company is developing MLR-1019 for the treatment of Parkinson's disease; and MLR -1023 to treat Type 1 diabetes. The company was formerly known as Marina Biotech, Inc. and changed its name to Adhera Therapeutics, Inc. in October 2018. Adhera Therapeutics, Inc. is based in Baton Rouge, Louisiana.
Company websiteResearch ATRX on Stk-Ai
Stk-Ai gives you screening across 100+ fundamental metrics, AI-powered analysis, target predictions, backtested signals, and portfolio tracking — all in one place.
Data shown is for informational purposes only and is not investment advice. Prices and metrics may be delayed.